Introduction: This study aims to report the efficacy and safety of capecitabine plus temozolomide (CAPTEM) across different lines of treatment in pati......
Ünal, C; Azizy, A; Karabulut, S; Tastekin, D; Akyildiz, A; Yasar, S; Yalcin, S; Coban, E; Evrensel, T; Kalkan, Z; Oruç, Z; Derin, S; Turna, ZH; Bayram, D; Kös, FT; Sendur, MAN; Sever, N; Ercelep, O; Seyyar, M; Kefeli, U; Uygun, K; Özcelik, M; Ön, S; Sanli, UA; Canaslan, K; Ünek, IT; Yücel, KB; Özdemir, N; Yazici, O; Güzel, HG; Salim, DK; Göksu, SS; Tatli, AM; Ordu, C; Selvi, O; Sakin, A; Büyükbayram, ME; Dursun, B; Ürün, Y; Arak, H; Agdas, G; Ugrakli, M; Hendem, E; Eryilmaz, MK; Bilgin, B; Topçu, A; Simsek, M; Büyüksimsek, M; Akay, B; Erdal, GS; Karatas, F; Alan, O; Caglayan, M; Kahvecioglu, FA; Demirci, A; Paksoy, N; Çetin, B; Gümüs, M; Ak, N; Aydinalp, Y; Paydas, S; Güven, DC; Kiliçkap, S; Saglam, S
Ünal, C (通讯作者),Kartal Dr Lutfi Kirdar City Hosp, Dept Internal Med, Div Med Oncol, Istanbul, Turkiye.
ONCOLOGIST, 2023; 28 (10): 875